Psychiatric Times, April 1, 2008 This study, by Dr. Karen Dineen Wagner, director of child and adolescent psychiatry at UTMB, was a multicenter, controlled treatment trial of children and adolescents. The aim of the study was to compare the efficacy and safety of risperidone and olanzapine with that of a traditional antipsychotic agent - molindone.